Skip to main content
Premium Trial:

Request an Annual Quote

Decode, Pfizer Collaborate on Sequence Variants for Lupus

NEW YORK (GenomeWeb News) – Decode Genetics today announced a research collaboration with Pfizer targeting sequence variants associated with specific clinical phenotypes related to systemic lupus erythematosis.

During the next 18 months, the firms will analyze the genomes of patients to discover sequence variants that could shed light on drug targets and lead to new drug targets.

Kari Stefansson, founder and CEO of Decode, based in Reykjavik, Iceland, said in a statement that the company's research platform "allows us to understand the genetic basis of disease and modifiers of clinical phenotypes in actual patient populations; by doing so, we can rapidly move from targets to patient stratification and from there to companion diagnostics."

Financial and other terms of the deal were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.